Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Int J Ophthalmol ; 17(3): 564-569, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38721505

RESUMO

AIM: To evaluate the efficacy of pneumatic retinopexy (PR) in patients undergoing PR as primary treatment for rhegmatogenous retinal detachment (RRD) and analyze the factors associated with success and failure in the studied population. METHODS: A retrospective chart review was done of patients with RRD treated with PR as primary management method treated at New York Eye and Ear Infirmary of Mount Sinai between January 2017 and December 2021. Primary outcome measured success or failure of PR. Secondary outcome measured best corrected visual acuity (BCVA) after PR. A separate risk analysis was done to identify and stratify risks associated with success and failure of PR. RESULTS: A total of 179 eyes from 179 patients were included for final analysis. The 83 patients (46.37%) achieved anatomical reattachment of the retina after primary PR with no need for additional surgery. The 96 patients (53.63%) had a failed primary PR and required a PPV and 6 of them required pars plana vitrectomy (PPV) with scleral buckle (SB). In total, 19 cases (10.61%) were done as temporizing pneumatics, 18 (94.74%) underwent PPV, and 1 (5.26%) did not require further intervention. The visual acuities at postoperative month 1 (POM1) for patients who underwent primary PR successfully and for those that underwent PPV after, were 0.58 (20/80) and 1.03 (20/200) respectively. Patients who met Pneumatic Retinopexy Versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT) criteria had a statistically significant decreased risk of primary PR failing (hazard ratio 0.29, P=0.00). Majority of missed or new breaks were found superotemporally. CONCLUSION: PR is a good treatment option for treating RRDs in patients that meet PIVOT criteria and can be conducted as a temporizing measure. PIVOT criteria and fovea on status decrease the risk of PR failure.

2.
Am J Ophthalmol Case Rep ; 25: 101394, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35198818

RESUMO

PURPOSE: To report the impact of intravitreal anti-vascular endothelial growth factor (VEGF) therapy on a retinal capillary hemangioma (RCH) using clinical OCT angiography (OCT-A) in addition to standard imaging modalities. OBSERVATIONS: A 25-year-old male patient with Von Hippel-Lindau (VHL) disease presented with a history of bilateral RCH. No view was present in the right eye. Examination of the left eye revealed six peripheral RCH, the smallest of which was temporal to the macula with active exudation. This RCH was thought to be the source of cystoid macular edema (CME) involving the fovea, and therefore, the source of vision decline. 11 injections of 1.25mg of Bevacizumab EA across 14-month was given. Comparison of the pre- and post-treatment OCT-A at the temporal RCH showed a reduction of CME and regression of RCH. CONCLUSION: Anti-VEGF therapy appeared to stabilize the visual acuity and produce partial regression of RCH. It offers a safe option when visual acuity is threatened. OCT and OCT-A have the ability to document the impact of antiangiogenic therapy on RCH. 3D renderings of OCT-A offer enhanced sensitivity to recognition of structural and functional changes of RCH which may prove useful for monitoring treatment response.

3.
Case Rep Ophthalmol Med ; 2021: 6816195, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34956683

RESUMO

While plasmapheresis is well known to significantly improve both retinal findings and systemic manifestations associated with Waldenstrom macroglobulinemia, few reports exist documenting changes in optical coherence tomography angiography (OCT-A). The authors present a case of a patient with Waldenstrom macroglobulinemia who had resolution of white-centered peripheral retinal lesions and parafoveal outer nuclear layer hyperreflective material following plasmapheresis. Applying image analysis software to before and after OCT-A images, the authors were able to show an objective decrease in retinal capillary and large vessel density following plasmapheresis. This technique can be used to guide treatment and surveillance for patients with hyperviscosity-related retinopathy.

4.
Ophthalmol Retina ; 5(8): 750-760, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-33130003

RESUMO

PURPOSE: To describe the incidence of subretinal deposits that are similar in structure and stage on OCT imaging to subretinal drusenoid deposits (SDDs) in age-related macular degeneration (AMD) in patients with hypertensive choroidopathy secondary to severe pre-eclampsia and malignant hypertension (MHT) and the implications of this ischemic choroidopathy for the pathophysiologic characteristics of SDDs in AMD. DESIGN: Retrospective cross-sectional study. PARTICIPANTS: Thirty-three pre-eclampsia patients and 25 MHT patients with serous retinal detachment (SRD) in at least 1 eye were included. METHODS: Serial multimodal images, including enhanced depth imaging spectral-domain OCT of eyes with hypertensive choroidopathy secondary to pre-eclampsia and MHT, were reviewed at 2 time points, the acute phase (within 4 weeks of initial hypertensive insult) and the recovery phase (beyond 4 weeks). MAIN OUTCOME MEASURES: Incidence of SDD-like lesions in patients with hypertensive choroidopathy secondary to pre-eclampsia and MHT. RESULTS: Subretinal drusenoid deposit-like lesions were observed exclusively in eyes with SRD. Serous retinal detachment occurred in 87.87% of eyes of pre-eclampsia patients and in 94% of eyes of MHT patients. Subretinal drusenoid deposit-like lesions occurred in 28.57% of all eyes with SRD, in 32.76% of eyes with SRD from the pre-eclampsia group, and in 23.40% of eyes with SRD from the MHT group. Vascular imaging suggested underlying choroidal ischemia in all patients (12 eyes) in which it was performed. CONCLUSIONS: Choroidal ischemia may be the underlying mechanism of SDD-like lesions in patients with pre-eclampsia and MHT choroidopathy. These findings potentially are of utmost importance in understanding the mechanism of the reticular macular disease subtype of AMD. Reticular macular disease is characterized by the known association of choroidal insufficiency and SDD, with choroidal insufficiency postulated, but not proven, to be causative. Pre-eclampsia and MHT choroidopathy seems to be a model for lesions similar to SDD in AMD developing based on choroidal insufficiency and, as such, may offer further insights into the pathoetiologic features of SDD in AMD.


Assuntos
Hipertensão Maligna/epidemiologia , Degeneração Macular/epidemiologia , Pré-Eclâmpsia/epidemiologia , Drusas Retinianas/epidemiologia , Adulto , Comorbidade , Estudos Transversais , Feminino , Angiofluoresceinografia/métodos , Seguimentos , Fundo de Olho , Humanos , Hipertensão Maligna/fisiopatologia , Degeneração Macular/diagnóstico , Oftalmoscopia , Pré-Eclâmpsia/diagnóstico , Pré-Eclâmpsia/fisiopatologia , Gravidez , Prognóstico , República da Coreia/epidemiologia , Drusas Retinianas/diagnóstico , Epitélio Pigmentado da Retina/patologia , Estudos Retrospectivos , Tomografia de Coerência Óptica/métodos
5.
Am J Ophthalmol Case Rep ; 20: 100871, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33083631

RESUMO

PURPOSE: To describe novel anatomic findings of an apparent choroidal macrovessel, originally misdiagnosed as a choroidal tumor, using non-invasive imaging tools. OBSERVATIONS: Initial ophthalmic examination revealed an elevated hypopigmented choroidal mass in the macular area, with a serpentine track extending temporally to the equator. Enhanced depth imaging optical coherence tomography (EDI-OCT) revealed an optically hollow lesion just outside the choroid-scleral junction (CSJ), indenting the retina and compressing the choroid from the scleral side. Optical coherence tomography angiography (OCTA) at the choroidal level showed relative low flow within the lesion. En face OCT at the level of the choroid demonstrated similar reflectivity to the physiological adjacent choroidal vessels. CONCLUSION AND IMPORTANCE: Non-invasive imaging can be used to demonstrate the presence and anatomy of a choroidal macrovessel. OCTA is presented as a useful diagnostic imaging test that can distinguish this lesion from alternative diagnoses without the use of dye injection. In addition to the previously published reports of such vessels in the choroid, we suggest a possible anatomic variant infra-choroidal location of a macrovessel and hypothesize its origin.

6.
Asia Pac J Ophthalmol (Phila) ; 9(3): 269-277, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32487917

RESUMO

The diagnosis and treatment of medical retinal disease is now inseparable from retinal imaging in all its multimodal incarnations. The purpose of this article is to present a selection of very different retinal imaging techniques that are truly translational, in the sense that they are not only new, but can guide us to new understandings of disease processes or interventions that are not accessible by present methods. Quantitative autofluorescence imaging, now available for clinical investigation, has already fundamentally changed our understanding of the role of lipofuscin in age-related macular degeneration. Hyperspectral autofluorescence imaging is bench science poised not only to unravel the molecular basis of retinal pigment epithelium fluorescence, but also to be translated into a clinical camera for earliest detection of age-related macular degeneration. The ophthalmic endoscope for vitreous surgery is a radically new retinal imaging system that enables surgical approaches heretofore impossible while it captures subretinal images of living tissue. Remote retinal imaging coupled with deep learning artificial intelligence will transform the very fabric of future medical care.


Assuntos
Inteligência Artificial , Angiofluoresceinografia/métodos , Degeneração Macular/diagnóstico , Oftalmoscopia/métodos , Epitélio Pigmentado da Retina/patologia , Tomografia de Coerência Óptica/métodos , Fundo de Olho , Humanos
7.
Rev. colomb. radiol ; 24(2): 3709-3712, 2014. ilus, graf
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-995644

RESUMO

En el siguiente artículo se describe el caso de un paciente de 48 años de edad, quien consultó a urgencias por un cuadro clínico de un mes de evolución de dolor retroesternal, asociado con disnea y deterioro de la clase funcional. El angio-TA C de tórax mostró derrame pericárdico, engrosamiento de las capas de pericardio y adenomegalias mediastinales. El paciente fue llevado a biopsia ganglionar y pericárdica con hallazgo histopatológico de mesotelioma pericárdico. El mesotelioma pericárdico es una enfermedad primaria maligna poco común, de etiología desconocida y con pocos casos descritos en Colombia, en el cual las células mesoteliales pericárdicas, que conforman una de las dos capas que constituyen el pericardio, sufren una transformación neoplásica. Las modalidades diagnósticas que mejor caracterizan este tipo de lesiones son la ecografía, la tomografía axial computarizada y la resonancia magnética.


The following article describes the case of a 48 year old male patient, who was admitted emergency care due to 1 month of retrosternal pain, associated with dyspnea and functional class deterioration. The CT angiogram of the chest revealed pericardial effusion, thickened pericardial layers and mediastinal lymphadenopathy. The patient underwent pericardial and lymph node biopsy with pericardial mesothelioma histopathological findings. Pericardial mesothelioma is a rare primary neoplastic disease, of unknown etiology, where pericardial mesothelial cells which make up one of the two layers that constitute the pericardium, undergo a neoplastic transformation. Only few cases are reported in Colombia. Diagnostic methods that best characterize this type of disease are echocardiography, computed axial tomography and magnetic resonance imaging.


Assuntos
Humanos , Pericárdio , Mesotelioma , Neoplasias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA